Steven R. Antico
Steven R. Antico
V-Card
- BIOGRAPHY
- Experience
- News
- Insights
Steven R. Antico is the Chair of Garfunkel Wild’s Behavioral Health and Medical and Education Services Practice Group. As a well-respected corporate and tax attorney, Steven focuses his practice in mergers, acquisitions, equity investments, including, private equity, venture capital, joint ventures, complex commercial transactions and arrangements, and general corporate governance matters. As a well-respected health care attorney, Steven routinely provides health care and regulatory guidance and compliance analysis (including, Stark Law and Anti-Kickback Law) to structure and consummate complex healthcare transactions.
Steven has substantial experience working with many kinds of health care and commercial businesses and organizations, and presently provides strategic and tactical guidance to enable clients to achieve goals, identify beneficial synergies, create alignment and consolidation strategies, enhance and expand existing business lines and develop new business lines and venture opportunities. With almost 30 years of experience, he is known as a business-oriented legal and business advisor with a demonstrated commitment to working with diverse cultures and communities throughout the region, and has created transformative relationships and alignment strategies for his clients. Steven also served with distinction as a Captain in the United States Marine Corps.
Steven presently represents and counsels:
- Private equity funds and venture capital investors;
- Medical Service Organizations (MSOs) and Dental Service Organizations (DSOs);
- Single-specialty and multi-specialty professional practices, clinically integrated networks and delivery models, independent practice associations, and Medicare Shared Savings ACOs and Managed Medicaid ACOs;
- Acute care and long-term care systems and providers;
- Ambulatory surgery centers, diagnostic imaging and testing facilities, and substance abuse and treatment facilities;
- Clinical laboratories and pharmacies; and
- Ancillary service providers that provide home health, home care, autism providers, therapy providers (inpatient and outpatient), medical and education based rehabilitation services, and numerous other services.
Representative Matters:
- Private Equity rollup of several hundred licensed/board certified behavioral analysts, licensed speech language, occupational and physical therapists, and licensed/certified special education and early intervention providers and development and implementation of MSO strategy.
- Private Equity rollup of numerous podiatry practices and development and implementation of MSO strategy.
- Rollup of numerous urology practices initially consisting of thirty-five (35) affiliated providers into a clinically and financially integrated single specialty group practice.
- Rollup of numerous primary care and specialty care medical practices initially consisting of thirty (30) affiliated providers into a clinically and financially integrated multi-specialty culturally specific group practice.
- Rollup of numerous medical oncology and radiation oncology medical practices initially consisting of sixty-three (63) affiliated providers into a clinically and financially integrated multi-specialty group practice.
- Development and representation of large dentistry practices and development and implementation of DSO strategies.
- Development and representation of large diagnostic imaging provider and affiliated diagnostic imaging facilities and development and implementation of DSO strategy.
- Structure and develop joint venture among acute care system and urgent care provider to develop and manage multiple urgent care facilities.
- Syndication of numerous ambulatory surgery centers.
Thirty-Eight Garfunkel Wild attorneys were selected by their peers for inclusion in the 2024 editions of The Best Lawyers in America and The Best Lawyers: Ones to Watch.
Thirty Five Garfunkel Wild attorneys were selected by their peers for inclusion in the 2023 The Best Lawyers in America® guide and the Best Lawyers “Ones to Watch” list. In addition, Partner Jason Y. Hsi was honored as “Lawyer of the Year” in the area of Litigation – Health Care Law.
27 Garfunkel Wild Attorneys Recognized In 2022 Best Lawyers In America List
2021 Best Lawyers In America® Lists Recognize 18 Garfunkel Wild Attorneys, Names One “Lawyer Of The Year”
Twelve Garfunkel Wild Partner/Directors were selected by their peers for inclusion in Best Lawyers in America for 2020.
Garfunkel Wild received prominent recognition in the 2025 editions of The Best Lawyers in America and The Best Lawyers in America: Ones to Watch. A total of 38 attorneys were honored with 59 individual recognitions across various practices and offices nationwide. Additionally, 3 Garfunkel Wild attorneys were distinguished as Lawyer of the Year, an accolade awarded to only one […]
On December 23, 2024, the Fifth Circuit Court of Appeals issued an order allowing the federal government to enforce the Corporate Transparency Act (CTA) and its “Reporting Rule.” Under that rule, the vast majority of privately held entities created or registered to do business in the United States (Reporting Companies) must report detailed information about their owners to the Financial Crimes Enforcement Network (FinCEN). The reporting requirement had been paused by a Texas federal district court just under three weeks earlier, on December 3, 2024. The Fifth Circuit ruling reverses the Texas district court’s ruling pending the government’s appeal.
On December 3, 2024, a federal district court in Texas issued a nationwide injunction that prohibits the federal government from enforcing the Corporate Transparency Act (CTA) and the regulation that requires corporate entities registered under state law to report detailed information about ownership.
Pursuant to the New Jersey Applied Behavior Analyst Licensing Act (the “Act”), the Board of Applied Behavior Analyst Examiners (the “Board”) published the official rules concerning the practice of Applied Behavior Analyst (“ABA”) therapy, effective May 6, 2024 (the “Rules”).
On March 1, 2024, the United States District Court for the Northern District of Alabama declared the Corporate Transparency Act (CTA) unconstitutional.
Steven R. Antico and J. David Morrissy will break down the Beneficial Ownership Information Reporting Requirements and how the requirements will affect your business.
On January 1, 2024, the United States Department of Treasury’s Financial Crimes Enforcement Network ("FinCEN") opened its Beneficial Ownership Secure System ("BOSS") portal to the public and began accepting Beneficial Ownership Information Reports ("BOI Reports") from Reporting Companies pursuant to the Corporate Transparency Act (“CTA”).
This alert is intended to warn recipients to be wary of fraudulent notices demanding recipients to provide their Beneficial Ownership Information ("BOI") through channels other than those secured by FinCEN.
As of January 1, 2024, many companies in the United States will have to file a Beneficial Ownership Information Report with FinCEN pursuant to the implementing regulations of the Corporate Transparency Act passed in 2021. Join us for an in-depth review of the Corporate Transparency Act.
Beginning on January 1, 2024, the Corporate Transparency Act (CTA) will require many companies to file a Beneficial Ownership Information (BOI) report with the Financial Crimes Enforcement Network (FinCEN).
The Board proposed new regulations regarding the practice of ABA therapy in New Jersey, including, for example, licensing standards for applied behavior analysts and assistant applied behavior analysts, reciprocity requirements, scope of services, business practices, and telehealth requirements.
Section 1115 of the Social Security Act provides the Secretary of Health and Human Services with the unique ability to approve demonstration projects (and establish pools for this purpose) that help further the goals of Medicaid programs.
On March 30, 2023, the Centers for Medicaid and Medicare Services ("CMS") approved New Jersey FamilyCare's Comprehensive 1115 Demonstration renewal. The renewal expands, amends and implements various projects and programs relating to Housing, Behavioral and Physical Health, and Worker Training that will enhance health care coverage, access and services to New Jersey FamilyCare members, which include Medicaid and CHIP beneficiaries.
Additional speaking & writing
Speeches and Events
- Understanding Tax-Related Provisions in LLC Operating Agreements, Hudson-Bergen Inn of Transaction Counsel, March 11, 2021
- MSOs: The Pathway To Value, New Jersey Institute of Continuing Legal Education, Mergers and Acquisitions Conference (October 28, 2020)
- “Healthcare Consolidations Panel,” panelist at the New Jersey State Bar Association (NJSBA) 2018 Health Law Symposium, Parsippany, NJ (October 19, 2018)
- Tax Considerations Related to Limited Liability Companies, New Jersey Institute for Continuing Legal Education, Fairfield, NJ (April 26, 2018)
- A General Primer of Health Care Issues for Transactional Attorneys, Essex Morris Inn of Transaction Counsel, Roseland, NJ (February 13, 2018)
- A General Primer of Health Care Issues for Transactional Attorneys, Bergen Hudson Inn of Transaction Counsel, Hackensack, NJ (February 8, 2018)
- Tax Considerations Related to Limited Liability Companies, New Jersey Institute for Continuing Legal Education, Fairfield, NJ (April 27, 2017)
Publications
- Administrative Barriers to Entry into the State of New Jersey for Professional Medical Practices, New Jersey Lawyer Magazine, October 2014
- Protecting against liability when ordering screening tests, Medical Economics, July 24, 2014
- Tax Implications of Practice Buy-ins, Buy-outs, Medical Economics, January 25, 2014
- Tax Principles Concerning Buy-ins, Buy-outs and Related Post-Withdrawal Compensation Issues, Chapter in Representing Physicians Handbook (Third Edition), American Health Lawyers Association, January 2013
Steven R. Antico is the Chair of Garfunkel Wild’s Behavioral Health and Medical and Education Services Practice Group. As a well-respected corporate and tax attorney, Steven focuses his practice in mergers, acquisitions, equity investments, including, private equity, venture capital, joint ventures, complex commercial transactions and arrangements, and general corporate governance matters. As a well-respected health care attorney, Steven routinely provides health care and regulatory guidance and compliance analysis (including, Stark Law and Anti-Kickback Law) to structure and consummate complex healthcare transactions.
Steven has substantial experience working with many kinds of health care and commercial businesses and organizations, and presently provides strategic and tactical guidance to enable clients to achieve goals, identify beneficial synergies, create alignment and consolidation strategies, enhance and expand existing business lines and develop new business lines and venture opportunities. With almost 30 years of experience, he is known as a business-oriented legal and business advisor with a demonstrated commitment to working with diverse cultures and communities throughout the region, and has created transformative relationships and alignment strategies for his clients. Steven also served with distinction as a Captain in the United States Marine Corps.
Steven presently represents and counsels:
- Private equity funds and venture capital investors;
- Medical Service Organizations (MSOs) and Dental Service Organizations (DSOs);
- Single-specialty and multi-specialty professional practices, clinically integrated networks and delivery models, independent practice associations, and Medicare Shared Savings ACOs and Managed Medicaid ACOs;
- Acute care and long-term care systems and providers;
- Ambulatory surgery centers, diagnostic imaging and testing facilities, and substance abuse and treatment facilities;
- Clinical laboratories and pharmacies; and
- Ancillary service providers that provide home health, home care, autism providers, therapy providers (inpatient and outpatient), medical and education based rehabilitation services, and numerous other services.
Representative Matters:
- Private Equity rollup of several hundred licensed/board certified behavioral analysts, licensed speech language, occupational and physical therapists, and licensed/certified special education and early intervention providers and development and implementation of MSO strategy.
- Private Equity rollup of numerous podiatry practices and development and implementation of MSO strategy.
- Rollup of numerous urology practices initially consisting of thirty-five (35) affiliated providers into a clinically and financially integrated single specialty group practice.
- Rollup of numerous primary care and specialty care medical practices initially consisting of thirty (30) affiliated providers into a clinically and financially integrated multi-specialty culturally specific group practice.
- Rollup of numerous medical oncology and radiation oncology medical practices initially consisting of sixty-three (63) affiliated providers into a clinically and financially integrated multi-specialty group practice.
- Development and representation of large dentistry practices and development and implementation of DSO strategies.
- Development and representation of large diagnostic imaging provider and affiliated diagnostic imaging facilities and development and implementation of DSO strategy.
- Structure and develop joint venture among acute care system and urgent care provider to develop and manage multiple urgent care facilities.
- Syndication of numerous ambulatory surgery centers.
Pursuant to the New Jersey Applied Behavior Analyst Licensing Act (the “Act”), the Board of Applied Behavior Analyst Examiners (the “Board”) published the official rules concerning the practice of Applied Behavior Analyst (“ABA”) therapy, effective May 6, 2024 (the “Rules”).
On March 1, 2024, the United States District Court for the Northern District of Alabama declared the Corporate Transparency Act (CTA) unconstitutional.
This alert is intended to warn recipients to be wary of fraudulent notices demanding recipients to provide their Beneficial Ownership Information ("BOI") through channels other than those secured by FinCEN.
On January 1, 2024, the United States Department of Treasury’s Financial Crimes Enforcement Network ("FinCEN") opened its Beneficial Ownership Secure System ("BOSS") portal to the public and began accepting Beneficial Ownership Information Reports ("BOI Reports") from Reporting Companies pursuant to the Corporate Transparency Act (“CTA”).
Beginning on January 1, 2024, the Corporate Transparency Act (CTA) will require many companies to file a Beneficial Ownership Information (BOI) report with the Financial Crimes Enforcement Network (FinCEN).
The Board proposed new regulations regarding the practice of ABA therapy in New Jersey, including, for example, licensing standards for applied behavior analysts and assistant applied behavior analysts, reciprocity requirements, scope of services, business practices, and telehealth requirements.
Section 1115 of the Social Security Act provides the Secretary of Health and Human Services with the unique ability to approve demonstration projects (and establish pools for this purpose) that help further the goals of Medicaid programs.
On March 30, 2023, the Centers for Medicaid and Medicare Services ("CMS") approved New Jersey FamilyCare's Comprehensive 1115 Demonstration renewal. The renewal expands, amends and implements various projects and programs relating to Housing, Behavioral and Physical Health, and Worker Training that will enhance health care coverage, access and services to New Jersey FamilyCare members, which include Medicaid and CHIP beneficiaries.
Steven R. Antico and J. David Morrissy will break down the Beneficial Ownership Information Reporting Requirements and how the requirements will affect your business.
As of January 1, 2024, many companies in the United States will have to file a Beneficial Ownership Information Report with FinCEN pursuant to the implementing regulations of the Corporate Transparency Act passed in 2021. Join us for an in-depth review of the Corporate Transparency Act.
On December 3, 2024, a federal district court in Texas issued a nationwide injunction that prohibits the federal government from enforcing the Corporate Transparency Act (CTA) and the regulation that requires corporate entities registered under state law to report detailed information about ownership.
On December 23, 2024, the Fifth Circuit Court of Appeals issued an order allowing the federal government to enforce the Corporate Transparency Act (CTA) and its “Reporting Rule.” Under that rule, the vast majority of privately held entities created or registered to do business in the United States (Reporting Companies) must report detailed information about their owners to the Financial Crimes Enforcement Network (FinCEN). The reporting requirement had been paused by a Texas federal district court just under three weeks earlier, on December 3, 2024. The Fifth Circuit ruling reverses the Texas district court’s ruling pending the government’s appeal.
On December 23, 2024, the Fifth Circuit Court of Appeals issued an order allowing the federal government to enforce the Corporate Transparency Act (CTA) and its “Reporting Rule.” Under that rule, the vast majority of privately held entities created or registered to do business in the United States (Reporting Companies) must report detailed information about their owners to the Financial Crimes Enforcement Network (FinCEN). The reporting requirement had been paused by a Texas federal district court just under three weeks earlier, on December 3, 2024. The Fifth Circuit ruling reverses the Texas district court’s ruling pending the government’s appeal.
On December 3, 2024, a federal district court in Texas issued a nationwide injunction that prohibits the federal government from enforcing the Corporate Transparency Act (CTA) and the regulation that requires corporate entities registered under state law to report detailed information about ownership.
Pursuant to the New Jersey Applied Behavior Analyst Licensing Act (the “Act”), the Board of Applied Behavior Analyst Examiners (the “Board”) published the official rules concerning the practice of Applied Behavior Analyst (“ABA”) therapy, effective May 6, 2024 (the “Rules”).
On March 1, 2024, the United States District Court for the Northern District of Alabama declared the Corporate Transparency Act (CTA) unconstitutional.
Steven R. Antico and J. David Morrissy will break down the Beneficial Ownership Information Reporting Requirements and how the requirements will affect your business.
On January 1, 2024, the United States Department of Treasury’s Financial Crimes Enforcement Network ("FinCEN") opened its Beneficial Ownership Secure System ("BOSS") portal to the public and began accepting Beneficial Ownership Information Reports ("BOI Reports") from Reporting Companies pursuant to the Corporate Transparency Act (“CTA”).
This alert is intended to warn recipients to be wary of fraudulent notices demanding recipients to provide their Beneficial Ownership Information ("BOI") through channels other than those secured by FinCEN.
As of January 1, 2024, many companies in the United States will have to file a Beneficial Ownership Information Report with FinCEN pursuant to the implementing regulations of the Corporate Transparency Act passed in 2021. Join us for an in-depth review of the Corporate Transparency Act.
Beginning on January 1, 2024, the Corporate Transparency Act (CTA) will require many companies to file a Beneficial Ownership Information (BOI) report with the Financial Crimes Enforcement Network (FinCEN).
The Board proposed new regulations regarding the practice of ABA therapy in New Jersey, including, for example, licensing standards for applied behavior analysts and assistant applied behavior analysts, reciprocity requirements, scope of services, business practices, and telehealth requirements.
Section 1115 of the Social Security Act provides the Secretary of Health and Human Services with the unique ability to approve demonstration projects (and establish pools for this purpose) that help further the goals of Medicaid programs.
On March 30, 2023, the Centers for Medicaid and Medicare Services ("CMS") approved New Jersey FamilyCare's Comprehensive 1115 Demonstration renewal. The renewal expands, amends and implements various projects and programs relating to Housing, Behavioral and Physical Health, and Worker Training that will enhance health care coverage, access and services to New Jersey FamilyCare members, which include Medicaid and CHIP beneficiaries.
Additional speaking & writing
Speeches and Events
- Understanding Tax-Related Provisions in LLC Operating Agreements, Hudson-Bergen Inn of Transaction Counsel, March 11, 2021
- MSOs: The Pathway To Value, New Jersey Institute of Continuing Legal Education, Mergers and Acquisitions Conference (October 28, 2020)
- “Healthcare Consolidations Panel,” panelist at the New Jersey State Bar Association (NJSBA) 2018 Health Law Symposium, Parsippany, NJ (October 19, 2018)
- Tax Considerations Related to Limited Liability Companies, New Jersey Institute for Continuing Legal Education, Fairfield, NJ (April 26, 2018)
- A General Primer of Health Care Issues for Transactional Attorneys, Essex Morris Inn of Transaction Counsel, Roseland, NJ (February 13, 2018)
- A General Primer of Health Care Issues for Transactional Attorneys, Bergen Hudson Inn of Transaction Counsel, Hackensack, NJ (February 8, 2018)
- Tax Considerations Related to Limited Liability Companies, New Jersey Institute for Continuing Legal Education, Fairfield, NJ (April 27, 2017)
Publications
- Administrative Barriers to Entry into the State of New Jersey for Professional Medical Practices, New Jersey Lawyer Magazine, October 2014
- Protecting against liability when ordering screening tests, Medical Economics, July 24, 2014
- Tax Implications of Practice Buy-ins, Buy-outs, Medical Economics, January 25, 2014
- Tax Principles Concerning Buy-ins, Buy-outs and Related Post-Withdrawal Compensation Issues, Chapter in Representing Physicians Handbook (Third Edition), American Health Lawyers Association, January 2013
Practices
Education
- Finance
Court admissions
New York Supreme Court, Appellate Division
New Jersey Supreme Court
PROFESSIONAL MEMBERSHIPS
- New Jersey State Bar Association Business Law Section, Health Section Committee Chair
AWARDS & RANKINGS
Best Lawyers in America® – Business Organizations (2016-2025)
America’s Leading Business Lawyers – Healthcare (Chambers and Partners, 2011, 2012)
Ranking Disclaimers: No aspect of this advertisement has been approved by the Supreme Court of New Jersey. For The Best Lawyers in America methodology, click here. For Super Lawyers methodology, click here.